Furosemide and Rectosigmoid cancer - a phase IV clinical study of FDA data

Summary:

Rectosigmoid cancer is reported as a side effect among people who take Furosemide (furosemide), especially for people who are female, 60+ old, also take Plavix, and have Deep venous thrombosis.

The phase IV clinical study analyzes which people have Rectosigmoid cancer when taking Furosemide. It is created by eHealthMe based on reports of 313,719 people who have side effects when taking Furosemide from the FDA, and is updated regularly.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

What is Rectosigmoid cancer?

Rectosigmoid cancer (cancer that originates in the rectum and sigmoid colon) is found to be associated with 38 drugs and 119 conditions by eHealthMe. Check the latest studies of Rectosigmoid cancer.

On Jul, 14, 2026

313,719 people reported to have side effects when taking Furosemide.
Among them, 24 people (0.01%) have Rectosigmoid cancer.

Could Furosemide cause Rectosigmoid cancer?

Among these 24 people:

What is the gender of people who have Rectosigmoid cancer when taking Furosemide? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Rectosigmoid cancer when taking Furosemide? *

What are other drugs people take besides Furosemide? *

What are other side effects people have besides Rectosigmoid cancer? *

Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 17 people, 70.83%
Colon Cancer: 15 people, 62.50%
Gastrointestinal Motility Disorder (abnormal intestinal contractions): 2 people, 8.33%
Metastases To Liver (cancer spreads to liver): 2 people, 8.33%
Constipation: 2 people, 8.33%
Diarrhea: 2 people, 8.33%
Inflammation: 2 people, 8.33%
Anorectal Disorder: 2 people, 8.33%
Microcytic Anaemia (a generic term for any type of anaemia characterized by small red blood cells): 2 people, 8.33%
Rectal Haemorrhage (bleeding from anus): 2 people, 8.33%

What are the existing conditions these people have? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 20 people, 83.33%
Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 19 people, 79.17%
Hypertriglyceridaemia (excess of triglycerides in the blood): 19 people, 79.17%
Cardiac Failure Congestive: 13 people, 54.17%
Cardiac Failure: 12 people, 50.00%
Embolism Venous (embolus may pass into the arterial system): 7 people, 29.17%
Type 1 Diabetes: 2 people, 8.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.33%
Essential Hypertension (primary hypertension): 2 people, 8.33%
Pain: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and have Rectosigmoid cancer?

- Check whether Rectosigmoid cancer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Furosemide:

Furosemide (316,095 reports)

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rectosigmoid cancer:

Rectosigmoid cancer (38 drugs)

Browse all the conditions that are associated with Rectosigmoid cancer:

Rectosigmoid cancer (119 conditions)

Related publications that referenced our studies

Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .
Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on furosemide (the active ingredients of Furosemide) and Furosemide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.